Aethlon Medical, Inc.
AEMD
$1.70
-$0.11-6.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -16.83% | -21.92% | -31.43% | -38.77% | -28.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.83% | -21.92% | -31.43% | -38.77% | -28.15% |
| Operating Income | 16.83% | 21.92% | 31.43% | 38.77% | 28.15% |
| Income Before Tax | 44.85% | 46.58% | -20.54% | 0.10% | -9.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 44.85% | 46.58% | -20.54% | 0.10% | -9.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.85% | 46.58% | -20.54% | 0.10% | -9.40% |
| EBIT | 16.83% | 21.92% | 31.43% | 38.77% | 28.15% |
| EBITDA | 17.25% | 22.57% | 32.33% | 39.81% | 28.86% |
| EPS Basic | 87.70% | 81.66% | 8.67% | -29.74% | -150.37% |
| Normalized Basic EPS | 87.79% | 81.72% | 8.83% | -29.55% | -150.37% |
| EPS Diluted | 87.70% | 81.66% | 8.67% | -29.74% | -150.37% |
| Normalized Diluted EPS | 87.79% | 81.72% | 8.83% | -29.55% | -150.37% |
| Average Basic Shares Outstanding | 496.88% | 331.28% | 264.67% | 260.11% | 693.55% |
| Average Diluted Shares Outstanding | 496.88% | 331.28% | 264.67% | 260.11% | 693.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |